International Screening Limits in plasma and signatory countries in the Asian region


Updated 26 October 2016

Drug ISL in Plasma (ng/ml) Codes of Signatory Countries#
Butorphanol 0.01 AU, HK, KR, SG, TH, ZA
Carprofen 100.0 AU, HK, JP, KR, SG, TH, ZA
Dembrexine 5.0 HK, SG, KR, TH, ZA
Flunixin 1.0 AU, HK, JP, SG, KR, TH, ZA
Furosemide 0.1 AU, HK, JP, SG, KR, TH, ZA
Phenylbutazone 100.0 AU, HK, JP, KR, SG, TH
Lidocaine 0.05 AU, HK, JP, KR, SG, TH, ZA
Mepivacaine 0.05 AU, HK, KR, SG, TH, ZA
Acepromazine 0.02 AU, HK, JP, KR, SG, TH, ZA
N-Butylscopolammonium 0.05 AU, HK, KR, SG, TH, ZA
Detomidine* 0.02 AU, HK, JP, KR, SG, TH, ZA
Meclofenamic Acid 5.0 AU, HK, JP, KR, SG, TH, ZA
Meloxicam 1.0 AU, HK, JP, MY, VN, ZA


'*Controlled by 3’-Hydroxydetomidine

'# Signatory countries in Asia that have adopted the individual ISL in plasma.

ARF Country codes: AU = Australia; BH = Bahrain; HK = Hong Kong; IN = India; JP = Japan; KR = Korea; MO = Macau; MY = Malaysia; MU = Mauritius; MN = Mongolia; NZ = New Zealand; OM = Oman; PK = Pakistan; PH = Philippines; QA = Qatar; SA = Saudi Arabia; SG = Singapore; ZA = South Africa; TH = Thailand; TM = Turkmenistan; TR = Turkey; AE = United Arab Emirates; VN = Vietnam.